We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 194

French company prevails in dispute with FDA over drug-classification ruling
  • Shook Hardy & Bacon LLP
  • USA
  • October 3 2012

A federal court in the District of Columbia has determined that the Food and Drug Administration (FDA) erred when it classified a combination drug-device product as primarily a drug, thus subjecting its French manufacturer to more burdensome regulatory requirements


USPTO seeks to intervene in publisher’s copyright infringement suit against law firm
  • Shook Hardy & Bacon LLP
  • USA
  • June 21 2012

The U.S. Patent and Trademark Office (USPTO) has filed a motion to intervene, and an answer and counterclaim, in litigation brought by scientific-journal publishers against a law firm for alleged copyright infringement involving articles on prior art copied and submitted with its clients’ patent applications


Dialysis equipment maker sues component part supplier for indemnification
  • Shook Hardy & Bacon LLP
  • USA
  • November 17 2011

A company that makes dialysis equipment for use in clinics and by patients in their homes has filed a complaint in federal court against a company that supplied a component part which allegedly contained a defect that led to a recall and caused injuries and at least one death


Federal Circuit explores when litigation is “reasonably foreseeable” for spoliation purposes
  • Shook Hardy & Bacon LLP
  • USA
  • May 19 2011

The Federal Circuit Court of Appeals has issued rulings in companion patent-infringement cases involving the alleged spoliation of documents; at issue was a determination as to when litigation is "reasonably foreseeable," thus triggering a document-preservation duty


Court orders dispute over 23andMe DNA test kits to arbitration
  • Shook Hardy & Bacon LLP
  • USA
  • July 17 2014

A multidistrict litigation court in California has ordered false-advertising, class-action claims filed against personal genetics company 23andMe to


Supplier sentenced for illegal sales of non-approved drugs
  • Shook Hardy & Bacon LLP
  • USA
  • June 26 2014

According to the U.S. Department of Justice, a federal court in Virginia has sentenced a U.S. citizen, who owned and operated several companies in


Class action filed against 23andMe, Inc. over efficacy of home DNA test kits
  • Shook Hardy & Bacon LLP
  • USA
  • January 30 2014

A New Mexico resident has filed a putative nationwide class action against 23andMe, Inc., alleging that claims for its DNA Collection Kits&mdash


Ambry Genetics countersues Myriad Genetics in genetic patent infringement suit
  • Shook Hardy & Bacon LLP
  • USA
  • August 15 2013

Responding to the patent infringement claims asserted against it by Myriad Genetics, Ambry Genetics Corp. denies that the 15 patents at issue were


Eighth Circuit says pleadings can be filed under seal, but needs more justification
  • Shook Hardy & Bacon LLP
  • USA
  • February 21 2013

The Eighth Circuit Court of Appeals has determined that a federal district court did not abuse its discretion in sealing an antitrust complaint


County pharmaceutical disposal law at issue before Ninth Circuit
  • Shook Hardy & Bacon LLP
  • USA
  • July 17 2014

The Ninth Circuit Court of Appeals has heard oral argument in an appeal challenging an Alameda County, California law that requires pharmaceutical